Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Kura Oncology
(NQ:
KURA
)
20.86
-0.23 (-1.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
444,643
Open
21.08
Bid (Size)
16.50 (1)
Ask (Size)
21.82 (1)
Prev. Close
21.09
Today's Range
20.40 - 21.41
52wk Range
7.410 - 24.17
Shares Outstanding
68,438,576
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
July 17, 2024
Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position.
Via
InvestorPlace
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
June 17, 2024
EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END
Via
FinancialNewsMedia
Performance
YTD
+35.81%
+35.81%
1 Month
-1.60%
-1.60%
3 Month
+3.99%
+3.99%
6 Month
+12.15%
+12.15%
1 Year
+99.81%
+99.81%
More News
Read More
2 Incredible Growth Stocks to Buy Hand Over Fist
May 08, 2024
Via
The Motley Fool
Kura Oncology Inc. (NASDAQ: KURA) is a Stock Spotlight on 3/6
March 06, 2024
Via
Investor Brand Network
Kura Oncology: Q4 Earnings Insights
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
Earnings Outlook For Kura Oncology
February 26, 2024
Via
Benzinga
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
June 17, 2024
From
FN Media Group LLC
Via
GlobeNewswire
KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024
May 02, 2024
Via
InvestorPlace
Kura Oncology Inc. (NASDAQ: KURA) Near the Top of Equities by Percentage Gain on 1/24
January 24, 2024
Via
Investor Brand Network
A Preview Of Kura Oncology's Earnings
November 01, 2023
Via
Benzinga
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
February 22, 2024
Via
Talk Markets
Kura Makes Good On Its $150 Million Infusion And Shoots Up Another 15%
January 30, 2024
Via
Investor's Business Daily
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 30, 2024
Via
Benzinga
Why Cancer-Drug Developer Kura Oncology Stock Is Up
January 30, 2024
Via
Benzinga
General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday
January 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Edges Lower; US Composite PMI Rises In January
January 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 24, 2024
Via
Benzinga
Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?
January 24, 2024
Via
Benzinga
Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On Wednesday
January 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Kura Oncology Rockets 39% Before Unveiling Cancer Drug Test Results — Here's Why
January 24, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 24, 2024
Via
Benzinga
Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: Analyst
December 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 27, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.